Halter J - Search Results

1

Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis.

Lee P, Chang A, Blaum C, Vlajnic A, Gao L, Halter J. Lee P, et al. Among authors: halter j. J Am Geriatr Soc. 2012 Jan;60(1):51-9. doi: 10.1111/j.1532-5415.2011.03773.x. J Am Geriatr Soc. 2012. PMID: 22239291 Free article. Clinical Trial.

2

Aging and insulin secretion.

Chang AM, Halter JB. Chang AM, et al. Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E7-12. doi: 10.1152/ajpendo.00366.2002. Am J Physiol Endocrinol Metab. 2003. PMID: 12485807 Free article. Review.

3

The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations.

Lee PG, Halter JB. Lee PG, et al. Diabetes Care. 2017 Apr;40(4):444-452. doi: 10.2337/dc16-1732. Diabetes Care. 2017. PMID: 28325795 Review.

4

Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people.

Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB, Supiano MA. Chang AM, et al. Among authors: halter jb. J Clin Endocrinol Metab. 2006 Feb;91(2):629-34. doi: 10.1210/jc.2005-1803. Epub 2005 Nov 29. J Clin Endocrinol Metab. 2006. PMID: 16317057

5

Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.

Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB. Chang AM, et al. Among authors: halter jb. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E906-11. doi: 10.1152/ajpendo.00156.2004. Epub 2004 Jun 22. Am J Physiol Endocrinol Metab. 2004. PMID: 15213063 Free article. Clinical Trial.

6

Diabetes and cardiovascular disease prevention in older adults.

Cigolle CT, Blaum CS, Halter JB. Cigolle CT, et al. Clin Geriatr Med. 2009 Nov;25(4):607-41, vii-viii. doi: 10.1016/j.cger.2009.09.001. Clin Geriatr Med. 2009. PMID: 19944264 Review.

7

Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance.

Chang AM, Smith MJ, Galecki AT, Bloem CJ, Halter JB. Chang AM, et al. Among authors: halter jb. J Clin Endocrinol Metab. 2006 Sep;91(9):3303-9. doi: 10.1210/jc.2006-0913. Epub 2006 Jun 6. J Clin Endocrinol Metab. 2006. PMID: 16757523 Clinical Trial.

8

Characteristics related to poor glycemic control in NIDDM patients in community practice.

Blaum CS, Velez L, Hiss RG, Halter JB. Blaum CS, et al. Among authors: halter jb. Diabetes Care. 1997 Jan;20(1):7-11. doi: 10.2337/diacare.20.1.7. Diabetes Care. 1997. PMID: 9028685

9

Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.

Subauste A, Gianani R, Chang AM, Plunkett C, Pietropaolo SL, Zhang YJ, Barinas-Mitchell E, Kuller LH, Galecki A, Halter JB, Pietropaolo M. Subauste A, et al. PLoS One. 2014 Sep 16;9(9):e106537. doi: 10.1371/journal.pone.0106537. eCollection 2014. PLoS One. 2014. PMID: 25226365 Free PMC article.

10

The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.

Chang AM, Jakobsen G, Sturis J, Smith MJ, Bloem CJ, An B, Galecki A, Halter JB. Chang AM, et al. Among authors: halter jb. Diabetes. 2003 Jul;52(7):1786-91. doi: 10.2337/diabetes.52.7.1786. Diabetes. 2003. PMID: 12829647 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

581 results

Search Page